Adrenal insufficiency

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 8, Issue 2, 2008, Pages 211-215

  Arlt, Wiebke ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; CORTICOTROPIN; CORTISONE ACETATE; DEXAMETHASONE; ETOMIDATE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; KETOCONAZOLE; MIFEPRISTONE; MINERALOCORTICOID; MITOTANE; PRASTERONE; PREDNISOLONE; RIFAMPICIN; SURAMIN; TETRACOSACTIDE;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; ASTHMA; CLINICAL FEATURE; CONTINUOUS INFUSION; CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC TEST; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG MONITORING; DRUG POTENCY; EPIDEMIOLOGICAL DATA; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; INSULIN TOLERANCE TEST; LOADING DRUG DOSE; OBESITY; OSTEOPOROSIS; PATHOGENESIS; PATIENT MONITORING; PREGNANCY; PROGNOSIS; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; SHORT SYNACTHEN TEST; SINGLE DRUG DOSE; SYMPTOMATOLOGY; WELLBEING;

EID: 42549103809     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.8-2-211     Document Type: Review

References (15)

1. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-93.
2. Stewart PM, Corrie J, Seckl JR, Edwards CR, Hadfield PL. A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1988;i:1208-10.
3. Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 2006;91:43-7.
4. Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal Cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) 1998;49:287-92.
5. Mah PM, Jenkins RC, Rostami-Hodjegan A et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004;61:367-75.
6. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 1997;46:263-8.
7. Monson JP. The assessment of glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 1997;46:269-70.
8. Arlt W, Rosenthal C, Hahner S, Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 2006;64:384-9.
9. Newell-Price J, Whiteman M, Rostami-Hodjegan A et al. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf) 2008;68:130-5.
10. Arlt W, Callies F, van Vlijmen JC et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-20.
11. Gurnell EM, Hunt PJ, Curran SE et al. Long-term DHEA replacement in primary adrenal insufficiency: a randomized controlled trial. J Clin Endocrinol Metab 2008;93:400-9.
12. Tomlinson JW, Holden N, Hills RK et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-31.
13. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006;91:4849-53.
14. Lovas K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 2002;56:581-8.
15. Hahner S, Loeffler M, Fassnacht M et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 2007;92:3912-22.